Cold chain capacity concerns around the world

The beginning of the year has brought a slew of announcements on various companies involved in manufacturing or transporting temperature-controlled pharmaceuticals. But the biggest news might be the preparations by the British government for a “hard” (no-deal) Brexit. In mid-January, […]

Read More

The scramble to ramp up CGT production

There’s a lot of sorting out going on in the world of cellular and genetic therapies (CGTs) when it comes to “manufacturing” and “dispensing.” Manufacturing is in quote marks because, unlike nearly all biopharma products, CGTs usually start with a […]

Read More